(Oslo, Norway, December 19, 2019) A closely related party to Runar Vatne, which is a Board Member and primary insider of Gentian Diagnostics AS, has today bought 2,000 shares in Gentian Diagnostics AS at price of NOK 54.926 per share.

Following the share purchase, Runar Vatne and closely related parties indirectly hold 2,232,224 shares in Gentian Diagnostics AS, corresponding to 14.5% of the outstanding shares.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.
Further information
Jens Borge-Andersen
Chief Financial Officer, Vatne Capital AS
E-mail: jba@vatnecapital.com Cell Phone: +47 95 75 60 10